Search Results 261-270 of 14928 for coq10

  1. A Study to Understand How Feedback from Breathing Muscles Influence Blood Flow and Blood Pressure during Exercise and if this can Reduce a Response in Heart Failure Patients with Breathing Muscle Training - Mayo Clinic

    A Study to Understand How Feedback from Breathing Muscles Influence Blood Flow and Blood Pressure during Exercise and if this can Reduce a Response in Heart ...

  2. What is peripheral artery disease? - Mayo Clinic

    PAD or peripheral arterial disease represents a chronic medical condition by which patients have plaque buildup inside the blood vessels, which limits the blood ...

  3. Timothy J. Hobday, M.D. - Mayo Clinic Faculty Profiles

    Timothy J. Hobday, M.D., a medical oncologist at Mayo Clinic, conducts clinical and translational research focused on neuroendocrine tumors.

  4. Nick T. Nicholson, M.D., Pharm.D. - Doctors and Medical Staff - Mayo Clinic

    2020 Outstanding Physician Scientist Educator AwardMayo Clinic School of Health-Related Sciences, Mayo Clinic College of Medicine and Science, Department of ...

  5. Atovaquone (oral route) - Mayo Clinic

    Atovaquone is used to prevent and treat Pneumocystis jiroveci pneumonia (PCP) in adults and children 13 years of age and older who cannot tolerate other ...

  6. Phase 2 Study of JK07 in Chronic Heart Failure - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. A Study Next Generation Sequencing (NGS) that May Help Identify Useful Genetic Information in Patients with Genetic Kidney Disease - Mayo Clinic

    The purpose of this study approach aims to identify exomic alterations that contribute to the development of kidney disease. Participation eligibility.

  8. Ana L. Creo, M.D. - Doctors and Medical Staff - Mayo Clinic

    Type 1 and 2 Diabetes; Diabetic Technology; Diabetes Prevention and Immunotherapy; Obesity and Pediatric Weight Management; Short Stature; Delayed Growth ...

  9. A Study to Evaluate Effectiveness and Safety of Lenzilumab in Hospitalized Patients with COVID-19 Pneumonia (Enrolling by Invitation Only) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/ ...